StockTipsArenaBeta

BUY Divi's Laboratories Limited — Sachin Janardan Sarvade, IDBI Capital Markets and Securities

BUYDivi's Laboratories Limited
Divi's Laboratories share price target & all analyst calls

bySachin Janardan Sarvade, IDBI Capital Markets and SecuritiesHorizon: NA (inferred Swing (≤2wk))8 Sept 2026via NDTV Profit (Live)

Entry₹9,375.5Inferred
Target₹11,100
Total upside +18.39% (call closed)
Stop loss₹8,449-9.88% risk
At expiry₹9,35222 Sept 2026, 3:30 pm
Expired-0.25%auction close
Follow Sachin Janardan Sarvade for new calls(13% target hit, 88 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 1 active Swing call on DIVISLABSee 144 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 22 Sept 2026
6 supporting1 neutral0 opposing
Supports the BUY call (6)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·17 Sept · 5d ago

Divi's Laboratories posts 65% PAT surge in Q1FY27 on strong revenue growth

NewsGoogle News·15 Sept · 6d ago

(opens in new tab)

Divi's Laboratories posts 65% PAT surge in Q1FY27 on strong revenue growth

NewsGoogle News·6 Sept · 2w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·26 Aug · 4w ago

PNB Housing, Divi's Labs Touch 52-Week Highs on Aug 26

NewsGoogle News·26 Aug · 4w ago

(opens in new tab)
Neutral / worth noting (1)

2 quiet pharma stocks are making very different cash bets. Add to watchlist?

NewsGoogle News·15 Sept · 1w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Divi's Laboratories

All analyst calls on Divi's Laboratories

More from Sachin Janardan Sarvade, IDBI Capital Markets and Securities

Every call and its outcome